At PromiseCare Medical Group in Hemet, California, prostate brachytherapy is a precise and minimally invasive treatment option for prostate cancer. This procedure involves implanting tiny radioactive seeds directly into the prostate gland, targeting cancer cells while minimizing damage to surrounding healthy tissue.
According to PromiseCare Medical Group’s data, brachytherapy has been shown to have fewer complications and side effects compared to external beam radiation therapy, making it a promising option for men with localized prostate cancer.
Patients undergo imaging tests and consultations with PromiseCare Medical Group’s healthcare providers to determine if this treatment is appropriate for them. The medical team guides them through the process.
As patients explore this treatment option, a more straightforward path emerges.
Overview
Prostate brachytherapy is a treatment option for localized prostate cancer that stands out for its precision and minimally invasive nature. This treatment involves implanting radioactive seeds directly into the prostate gland, where they target cancer cells while minimizing damage to surrounding tissues. The procedure typically takes under an hour and is guided by ultrasound imaging to ensure precise seed placement.
Brachytherapy is associated with fewer complications and side effects compared to traditional external beam radiation therapy, making it an attractive option for early-stage prostate cancer.
There are two main types of brachytherapy: Low-Dose Rate (LDR) and High-Dose Rate (HDR). After treatment, prostate-specific antigen (PSA) levels are closely monitored to assess the effectiveness of the treatment and identify any potential recurrence of cancer.
Brachytherapy allows for precise targeting of cancer cells while minimizing harm to surrounding tissues. Its benefits should be considered when weighing treatment options.
Types
When considering prostate brachytherapy as a treatment option, understanding the different approaches available is essential.
Two main types of brachytherapy exist: Low Dose Rate (LDR) and High Dose Rate (HDR). LDR involves permanent radioactive seed implants that release radiation over several months, suitable for localized prostate cancer with a high success rate and minimal side effects. HDR uses temporary radioactive pellets placed in the prostate for short durations, often recommended for more advanced cases or as a complement to external beam radiation therapy.
During LDR procedures, which last just over an hour, radioactive seeds are implanted through the perineum using ultrasound guidance. HDR brachytherapy, on the other hand, can be completed in about 30 minutes.
Both types utilize advanced imaging techniques to guarantee precise seed placement and superior radiation delivery to the tumor site. The choice between LDR and HDR depends on factors such as cancer stage, patient health, and treatment goals. Careful planning is required to maximize effectiveness and minimize side effects. Understanding the different types of brachytherapy is crucial for making an informed treatment decision.
Why it’s done
Prostate cancer can be a life-altering diagnosis, making it crucial to evaluate the most effective treatment options available. For localized cancer, prostate brachytherapy is a viable treatment that delivers high doses of radiation directly to the tumor, minimizing damage to surrounding healthy tissues. This approach requires fewer healthcare visits compared to external beam radiation therapy, making it a more convenient option.
Brachytherapy utilizes advanced imaging technologies, such as ultrasound and MRI, to ensure accurate seed placement and ideal treatment planning, which results in better outcomes and fewer side effects.
Brachytherapy can also serve as a salvage treatment for those who’ve had previous radiation therapy, offering a lower risk of complications than traditional surgery. By targeting the tumor with precision and care, individuals can take a vital step toward managing their cancer and reclaiming their lives.
Brachytherapy offers a path that balances effectiveness with a better quality of life.
Who it’s for
Prostate brachytherapy is a treatment option specifically designed for men with localized, early-stage prostate cancer that’s slow-growing and confined to the prostate gland. Three key considerations must be met:
- Localized cancer: The cancer is contained within the prostate gland, making it an ideal target for brachytherapy.
- Recurrent cancer: Brachytherapy can be a salvage treatment option for men who’ve had previous radiation therapy, with fewer side effects than surgery.
- Pre-treatment evaluations: Imaging tests such as ultrasounds and MRIs are used to determine the appropriateness of brachytherapy based on tumor size and location. Understanding who brachytherapy is for is crucial in making an informed treatment decision. Brachytherapy may be used alone or in combination with external beam radiation therapy or hormone therapy to achieve the best results. A healthcare provider should discuss the potential benefits and limitations of brachytherapy to determine if it’s the right treatment option.
Risks
Prostate brachytherapy carries potential risks that should be weighed against its benefits. Urinary symptoms, such as increased frequency, urgency, or discomfort during urination, can affect up to 30% of patients.
Erectile dysfunction is another possible side effect, impacting about 20-30% of men. Bowel issues, including diarrhea or rectal discomfort, may occur in approximately 5-10% of patients. Infection at the seed implantation site is a rare but serious risk, occurring in about 1-2% of cases, and requires careful monitoring and potential antibiotic treatment.
Long-term radiation effects can lead to complications like fibrosis or chronic pain, although these occurrences are generally infrequent and vary per individual.
Discussing these risks with a healthcare provider and understanding the monitoring and management strategies can help minimize them. Acknowledging these potential challenges can lead to a more informed decision about treatment and better preparation for the journey ahead.
How you prepare
Preparing for prostate brachytherapy requires careful planning and attention to detail. Imaging tests, such as ultrasounds, CT scans, or MRIs, are used to plan treatment and ensure accurate seed placement. These tests provide a clear picture of the prostate cancer and its exact location.
A consultation is necessary to discuss the procedure, potential risks, and individual treatment plans; this is an opportunity to ask questions and express concerns.
Specific preparations are necessary:
- Stopping certain medications: Blood thinners may need to be stopped several days before the procedure to reduce the risk of bleeding.
- Undergoing pre-treatment evaluations: Blood tests and heart evaluations are required to ensure safety during anesthesia administration.
- Quitting smoking: Smoking cessation is recommended to improve treatment outcomes and recovery.
What you can expect
Undergoing brachytherapy for prostate cancer can be a life-changing experience, and it’s natural to wonder what to expect from the treatment. The procedure is a significant step in combating the disease.
Anesthesia will be administered to ensure comfort during the treatment, which may leave the patient drowsy but awake or asleep and pain-free—depending on the type of anesthesia used. Imaging guidance, such as ultrasound or CT scans, will help precisely place radioactive seeds within the prostate gland.
These seeds will become permanent implants for Low-Dose Rate (LDR) brachytherapy. The procedure lasts over 30 minutes and varies depending on whether LDR or High-Dose Rate (HDR) therapy is utilized.
Patients may experience mild pain, tenderness, or sleepiness following the treatment, but most are discharged on the same day. As they recover, they must remember that the permanent implants will remain in their bodies, and radiation levels will diminish over time.
This treatment is an essential step towards combating prostate cancer.
Results
Treatment is complete, and the seeds of hope have been sown. Now, the wait begins to see the results of prostate brachytherapy. Anxiety to know if the treatment has been effective in controlling localized prostate cancer is routine.
Regular follow-up tests will be conducted to monitor PSA levels during the post-treatment phase. A temporary spike in PSA levels, known as a PSA bounce, may occur and is a common phenomenon. Progress will be closely tracked, and with time, PSA levels should decline, indicating the treatment’s effectiveness.
Three key things to keep in mind while awaiting results:
- Survival rate: The five-year survival rate for patients with localized prostate cancer treated with brachytherapy is around 90%.
- Side effects: Ongoing urinary symptoms and changes in sexual function may persist for months or years after treatment.
- Treatment success: The success of brachytherapy depends on factors such as cancer stage, Gleason score, and patient health. Early-stage, low-risk patients show the most favorable outcomes.
Staying vigilant and discussing any concerns with a healthcare team is essential. Regular follow-up appointments will help monitor progress and address any side effects or problems.